A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
Clinical trial NCT03033303 · COMPLETED
Trial details
- NCT number
- NCT03033303
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2025-09-29
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.